EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES

Large epidemiological trails shown that hypercholesterolemia is one of the main risk factor of ischemic heart disease (IHD). Correction of the hypercholesterolemia with GmGKoA reductase inhibitors (statins) essentially reduces IHD morbidity and mortality. The lower serum level of low density lipopro...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteur: A. N. Meshkov
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Reeks:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Onderwerpen:
hypercholesterolemia
ischemic heart disease
atorvastatin
Online toegang:https://www.rpcardio.com/jour/article/view/820
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items